|
NUFIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05990779988952E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84390280821844E-11 |
| Normal-vs-Stage2 |
1.9966599999921E-05 |
| Normal-vs-Stage3 |
2.72949995938632E-10 |
| Normal-vs-Stage4 |
2.04269934300783E-11 |
| Stage1-vs-Stage2 |
7.585200E-01 |
| Stage1-vs-Stage3 |
3.342800E-01 |
| Stage1-vs-Stage4 |
2.116000E-02 |
| Stage2-vs-Stage3 |
3.878800E-01 |
| Stage2-vs-Stage4 |
9.213900E-02 |
| Stage3-vs-Stage4 |
2.258800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.76205749780456E-14 |
| Normal-vs-AfricanAmerican |
6.600600E-04 |
| Normal-vs-Asian |
3.59240000002981E-06 |
| Caucasian-vs-AfricanAmerican |
3.580400E-01 |
| Caucasian-vs-Asian |
2.024400E-01 |
| AfricanAmerican-vs-Asian |
9.893000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.05235869702392E-12 |
| Normal-vs-Female |
1.25920385229961E-11 |
| Male-vs-Female |
1.219620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38140054950497E-10 |
| Normal-vs-Age(41-60Yrs) |
3.41670025605367E-11 |
| Normal-vs-Age(61-80Yrs) |
1.45940004525613E-09 |
| Normal-vs-Age(81-100Yrs) |
6.202200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.872000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.876800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.860600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.437200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.378200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.892200E-01 |
| Classical-VS-Follicular |
5.850200E-01 |
| Classical-VS-Other |
1.951780E-01 |
| Classical-VS-Normal |
2.36609620785089E-11 |
| Tall-VS-Follicular |
6.148400E-01 |
| Tall-VS-Other |
4.600200E-01 |
| Tall-VS-Normal |
7.10280000038033E-07 |
| Follicular-VS-Other |
3.818800E-01 |
| Follicular-VS-Normal |
1.40990000008223E-07 |
| Other-VS-Normal |
6.986300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.11679595863279E-11 |
| Normal-vs-N1 |
5.32370036943064E-10 |
| N0-vs-N1 |
2.523800E-01 |
|
|
